Kim Gannon: Women Have Unique Stroke Risk Factors and The Warning Signs Can Look Different
Kim Gannon, Physician Executive of Neurosciences at ChristianaCare, shared on LinkedIn:
”Today I had the privilege of attending the American Heart Association Go Red for Women luncheon and being the ‘pop-up doc’ for some incredible conversations about heart and brain health.
May is American Stroke Month, and it’s a good time to say this plainly: stroke is one of the leading killers of women – and one of the most preventable.
A few things I wish more women knew:
- Women have unique stroke risk factors – including pregnancy complications, hormonal contraception, migraine with aura, and autoimmune disease
- The warning signs can look different – fatigue, confusion, and sudden headache are easy to dismiss
- Time is brain – every minute of delay costs neurons. Know FAST. Call 911.
The conversations at today’s luncheon reminded me why this work matters beyond the hospital walls.
Getting to meet women where they are – curious, engaged, and ready to advocate for their own health – is one of the best parts of this work.
To every woman who stopped to ask a question today: your brain (and heart) thank you.”

Stay updated with Hemostasis Today.
-
Aug 21, 2026, 12:42Moustafa Abdou: Pyruvate Kinase Deficiency Recognising an Underdiagnosed Cause of Chronic Haemolysis
-
Aug 21, 2026, 12:38Luluva Ghadiyali: Modern Approaches to Aplastic Anemia
-
Aug 21, 2026, 12:34Kellie Machlus: Animal Models Driving Progress in Thrombosis Research
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida